May11

Solid Biosciences to Initiate Clinical Program for Gene Therapy Candidate in Coming Months

Mar30

Company to Use Proceeds to Advance Programs for Duchenne Muscular Dystrophy.

Nov25

To advance the development of its gene therapy platform for Duchenne muscular dystrophy.

  •  

More information about Solid?

Please subscribe to receive our latest news